Phillip Gorelick
Vascular Neurology · Chicago, ILNPI 1902841273
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $268,812 of the $268,899 with a category attached, or 100.0%. It is spread thinly across 15 manufacturers, the largest accounting for just 23.4%. Reporting peaked in 2021 at $93,583 and has fallen 86.7% since, to $12,416 in 2025. Among vascular neurology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 245 payments — averaging $1097.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$63K
- UCB SA$36K
- E.r. Squibb & Sons, L.L.C.$31K
- Amgen$26K
- Astrazeneca UK Limited$23K
- Redhill Biopharma Inc.$23K
- plus $67K from 9 others
Across 81 payments — averaging $1298.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$32K
- Astrazeneca UK Limited$30K
- E.r. Squibb & Sons, L.L.C.$14K
- Novartis Pharma AG$13K
- AstraZeneca$10K
- Amgen$3K
- plus $3K from 2 others
What the payments were for
- Consulting fees$268,812100%
- Food & beverage$870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 56 | $62,817 |
| UCB SA | 44 | $35,790 |
| E.r. Squibb & Sons, L.L.C. | 21 | $31,427 |
| Amgen | 12 | $26,125 |
| Astrazeneca UK Limited | 40 | $23,136 |
| Redhill Biopharma Inc. | 5 | $22,892 |
| UCB Biosciences Inc. | 24 | $22,270 |
| AbbVie(2 entities) | 13 | $21,918 |
| UCB GmbH | 6 | $5,910 |
| Sanofi-aventis U.S. LLC | 13 | $5,534 |
| Sanofi US Services Inc. | 4 | $5,393 |
| Janssen Research & Development, LLC | 2 | $3,800 |
| Pfizer | 2 | $1,250 |
| Alnylam Pharmaceuticals Inc. | 1 | $625 |
| Hologic Inc | 2 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$268,899 in reported general payments places this provider in the 95th percentile of 32 vascular neurology providers in Illinois.
Other vascular neurology in Chicago
- Tareq Kass-HoutChicago$336K
- Richard BernsteinChicago$114K
- Yvonne CurranChicago$26K
- Fan CaprioChicago$9K
- Lesli SkolarusChicago$8K
- Monika ManchandaChicago$2K
- Sebastian UrdayChicago$1K
- Aisha AliChicago$640
- Silvya SotoChicago$349
- Gabriela TrifanChicago$126
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.